Evidence map›Paper›PMID 36330198›Full record

ArticleCurrent opinion in systems biology2020

Engineering cell fate: Applying synthetic biology to cellular reprogramming.

Nathan B Wang, Adam M Beitz, Kate E Galloway

Abstract read
In one paragraph

Article in Current opinion in systems biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Reversing transgene silencing via targeted chromatin editing.bioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Accelerating Diverse Cell-Based Therapies Through Scalable Design.Annual review of chemical and biomolecular engineering · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nathan B WangDepartment of Chemical Engineering, MIT, 25 Ames St., Cambridge, MA, 02139, USA.
Adam M BeitzDepartment of Chemical Engineering, MIT, 25 Ames St., Cambridge, MA, 02139, USA.
Kate E GallowayDepartment of Chemical Engineering, MIT, 25 Ames St., Cambridge, MA, 02139, USA.

Funding

Identifying the mechanisms of neuronal fate commitment during direct conversionF32NS092417 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GALLOWAY, KATE ELIZABETH · 2015 to 2017
$173k
NINDS NIH HHS F32 NS092417
6 · The paper itself

Abstract

Cellular reprogramming drives cells from one stable identity to a new cell fate. By generating a diversity of previously inaccessible cell types from diverse genetic backgrounds, cellular reprogramming is rapidly transforming how we study disease. However, low efficiency and limited maturity have limited the adoption of

Indexed as

BarcodingCell fateCell stateCellular reprogrammingDeliveryEpigeneticsGene circuitsGene regulatory networksLatent donor identityLineage tracingSignalingSynthetic biology

Identifiers

PMID36330198
PMCPMC9629175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.